Globus Medical (GMED)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $9.34B
Last updated: Nov 17, 2026 at 5:25 PM ET
Globus Medical (GMED) Stock Chart
Globus Medical (GMED) has a latest price of $70.02 on Nov 17, 2026. Its price fell 17.1% over the past 12 months. The month-end price rose 252.7% over the 10 years through Oct 2026, a compound annual rate of 13.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $95.46 in Feb 2026 and its lowest $21.64 in Nov 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GMED with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GMED.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 20.7%, and over 6 months it fell 12.4%. The month-end price rose 70.8% over the 3 years through Oct 2026, a compound annual rate of 19.5%.
| Period | Change |
|---|---|
| 1 month | -7.4% |
| 3 months | -20.7% |
| 6 months | -12.4% |
| 12 months | -17.1% |
| 12 months, with dividends | -17.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +70.8% | +19.5% |
| 5 years | +1.1% | +0.2% |
| 10 years | +252.7% | +13.4% |
Price by Year
Its best calendar year was 2017, when the price rose 65.7%, and its weakest was 2023, when it fell 28.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $78.05 | -10.6% |
| 2025 | $87.31 | +5.6% |
| 2024 | $82.71 | +55.2% |
| 2023 | $53.29 | -28.2% |
| 2022 | $74.27 | +2.9% |
| 2021 | $72.20 | +10.7% |
| 2020 | $65.22 | +10.8% |
| 2019 | $58.88 | +36.0% |
| 2018 | $43.28 | +5.3% |
| 2017 | $41.10 | +65.7% |
Trading Range
The price is 8.2% below its 50-day average of $76.30 and 15.1% below its 200-day average of $82.50.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $70.02 | |
| 50-day average | $76.30 | -8.2% |
| 200-day average | $82.50 | -15.1% |
Price Risk
Over 3 years, its largest fall from a peak was 44.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.91 |
| Largest fall, 1 year | -27.7% |
| Largest fall, 3 years | -44.4% |
Valuation
Globus Medical traded at 21.8x earnings at the end of 2025, against a 5-year median of 25.1x and a 10-year median of 27.7x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GMED
What is GMED's 1-year price change?
Globus Medical's price fell 17.1% over the past 12 months. With dividends included, the 12-month total return was -17.1%.
What is GMED's 5-year price change?
Globus Medical's month-end price rose 1.1% over the 5 years through Oct 2026, a compound annual rate of 0.2%. These figures leave out dividends.
What is GMED's beta?
Globus Medical's 1-year beta against the S&P 500 is 0.91, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 27.7%.
Is the GMED chart free?
Yes. Advanced Charting for GMED is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GMED pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts